These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

576 related items for PubMed ID: 10360125

  • 1. Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients.
    Nyberg S, Eriksson B, Oxenstierna G, Halldin C, Farde L.
    Am J Psychiatry; 1999 Jun; 156(6):869-75. PubMed ID: 10360125
    [Abstract] [Full Text] [Related]

  • 2. A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy.
    Kapur S, Zipursky R, Jones C, Shammi CS, Remington G, Seeman P.
    Arch Gen Psychiatry; 2000 Jun; 57(6):553-9. PubMed ID: 10839333
    [Abstract] [Full Text] [Related]

  • 3. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
    Kapur S, Zipursky RB, Remington G.
    Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
    [Abstract] [Full Text] [Related]

  • 4. 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.
    Kapur S, Zipursky RB, Remington G, Jones C, DaSilva J, Wilson AA, Houle S.
    Am J Psychiatry; 1998 Jul; 155(7):921-8. PubMed ID: 9659858
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study.
    Graff-Guerrero A, Rajji TK, Mulsant BH, Nakajima S, Caravaggio F, Suzuki T, Uchida H, Gerretsen P, Mar W, Pollock BG, Mamo DC.
    JAMA Psychiatry; 2015 Sep; 72(9):927-34. PubMed ID: 26131622
    [Abstract] [Full Text] [Related]

  • 6. A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone.
    Remington G, Mamo D, Labelle A, Reiss J, Shammi C, Mannaert E, Mann S, Kapur S.
    Am J Psychiatry; 2006 Mar; 163(3):396-401. PubMed ID: 16513859
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study.
    Mamo D, Graff A, Mizrahi R, Shammi CM, Romeyer F, Kapur S.
    Am J Psychiatry; 2007 Sep; 164(9):1411-7. PubMed ID: 17728427
    [Abstract] [Full Text] [Related]

  • 8. Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients.
    Dresel S, Tatsch K, Dähne I, Mager T, Scherer J, Hahn K.
    J Nucl Med; 1998 Jul; 39(7):1138-42. PubMed ID: 9669383
    [Abstract] [Full Text] [Related]

  • 9. Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia.
    Gefvert O, Bergström M, Långström B, Lundberg T, Lindström L, Yates R.
    Psychopharmacology (Berl); 1998 Jan; 135(2):119-26. PubMed ID: 9497016
    [Abstract] [Full Text] [Related]

  • 10. High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study.
    Kapur S, Remington G, Jones C, Wilson A, DaSilva J, Houle S, Zipursky R.
    Am J Psychiatry; 1996 Jul; 153(7):948-50. PubMed ID: 8659621
    [Abstract] [Full Text] [Related]

  • 11. Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia.
    Kapur S, Zipursky R, Jones C, Remington G, Houle S.
    Am J Psychiatry; 2000 Apr; 157(4):514-20. PubMed ID: 10739409
    [Abstract] [Full Text] [Related]

  • 12. D2 dopamine receptor occupancy, risperidone plasma level and extrapyramidal motor symptoms in previously drug-free schizophrenic patients.
    Regenthal R, Kunstler U, Hesse S, Sabri O, Preiss R.
    Int J Clin Pharmacol Ther; 2005 Aug; 43(8):370-8. PubMed ID: 16119512
    [Abstract] [Full Text] [Related]

  • 13. Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients.
    Nordström AL, Farde L, Wiesel FA, Forslund K, Pauli S, Halldin C, Uppfeldt G.
    Biol Psychiatry; 1993 Feb 15; 33(4):227-35. PubMed ID: 8097114
    [Abstract] [Full Text] [Related]

  • 14. D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients.
    Nordström AL, Farde L, Nyberg S, Karlsson P, Halldin C, Sedvall G.
    Am J Psychiatry; 1995 Oct 15; 152(10):1444-9. PubMed ID: 7573582
    [Abstract] [Full Text] [Related]

  • 15. PET measurement of neuroreceptor occupancy by typical and atypical neuroleptics.
    Goyer PF, Berridge MS, Morris ED, Semple WE, Compton-Toth BA, Schulz SC, Wong DF, Miraldi F, Meltzer HY.
    J Nucl Med; 1996 Jul 15; 37(7):1122-7. PubMed ID: 8965181
    [Abstract] [Full Text] [Related]

  • 16. A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone.
    Mamo D, Kapur S, Shammi CM, Papatheodorou G, Mann S, Therrien F, Remington G.
    Am J Psychiatry; 2004 May 15; 161(5):818-25. PubMed ID: 15121646
    [Abstract] [Full Text] [Related]

  • 17. Implications of brain imaging for the management of schizophrenia.
    Nyberg S, Nilsson U, Okubo Y, Halldin C, Farde L.
    Int Clin Psychopharmacol; 1998 Mar 15; 13 Suppl 3():S15-20. PubMed ID: 9690965
    [Abstract] [Full Text] [Related]

  • 18. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.
    Agid O, Mamo D, Ginovart N, Vitcu I, Wilson AA, Zipursky RB, Kapur S.
    Neuropsychopharmacology; 2007 Jun 15; 32(6):1209-15. PubMed ID: 17077809
    [Abstract] [Full Text] [Related]

  • 19. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.
    Yokoi F, Gründer G, Biziere K, Stephane M, Dogan AS, Dannals RF, Ravert H, Suri A, Bramer S, Wong DF.
    Neuropsychopharmacology; 2002 Aug 15; 27(2):248-59. PubMed ID: 12093598
    [Abstract] [Full Text] [Related]

  • 20. Quetiapine: an effective antipsychotic in first-episode schizophrenia despite only transiently high dopamine-2 receptor blockade.
    Tauscher-Wisniewski S, Kapur S, Tauscher J, Jones C, Daskalakis ZJ, Papatheodorou G, Epstein I, Christensen BK, Zipursky RB.
    J Clin Psychiatry; 2002 Nov 15; 63(11):992-7. PubMed ID: 12444812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.